ISPAD Annual Meeting in Montreal 2025
Visit our booth and discover what’s new!
Enhancing quality of life for people with diabetes
Ypsomed Diabetes Care AG is becoming mylife Diabetes Care AG, a company fully dedicated to improving the lives of people living with diabetes. The new name builds on the established mylife Diabetes Care portfolio and reflects the company’s long-standing commitment to innovation in insulin infusion systems.
We’re excited to return to the ISPAD Annual Meeting this time under our new company name.
Visit us at Congress Booth 9 and engage directly with our medical experts.
Explore the latest features of the automated insulin delivery system myLoop. Learn how it enables discreet and adaptable diabetes management throughout daily life, including periods of increased activity and movement.
Our experts will share how optimal blood glucose levels can be supported during all stages of childbirth. Gain exclusive insights into using CamAPS FX.
A new milestone: myLoop now available for iPhone*
People with type 1 diabetes now have greater freedom of choice. It offers various options for remote monitoring and data sharing with a diabetes care team or “companions” such as family members or friends.
The CamAPS FX app brings its trusted features to iOS, offering its smart and convenient way to manage type 1 diabetes. Alongside modes like ‘Boost’ and ‘Ease-off’, the system enables personalised glucose targets tailored to the child’s daily routine. The CamAPS FX app on iPhone is compatible with the FreeStyle Libre 3, FreeStyle Libre 3 Plus and with Dexcom G6 CGM sensors.
Symposium
November 07, 2025 | 8:00 AM – 9:00 AM
From Research to Real Life: Optimising CamAPS FX in Paediatric Type 1 Diabetes
Clinical insights, practical strategies, and everyday perspectives in one session
This symposium showcases the latest evidence, practical strategies, and real-life perspectives on using myLoop powered by CamAPS FX in children with type 1 diabetes. From clinical insights to everyday experience, gain valuable knowledge to support safe and effective use in practice.
Chair: Dr. Laurent Legault
Paediatric Endocrinologist, Montreal Children’s Hospital, and Associate Professor, McGill University (Canada).
Dr. Legault specializes in type 1 diabetes, Paediatric obesity, and metabolic disorders. A pioneer in insulin pump therapy and artificial pancreas research in Québec, he currently directs the Division of Paediatric Endocrinology & Metabolism at McGill University.
Speaker: Dr. Martin Tauschmann
Paediatrician and clinical researcher specialising in diabetes technology and paediatric endocrinology. After medical studies and the start of his paediatric training in Graz, he joined Prof. Roman Hovorka's group at the University of Cambridge as a clinical research associate, where he also completed a PhD on closed-loop insulin delivery in children with type 1 diabetes. He then continued his paediatric specialisation at the Medical University of Vienna, contributing to international multicenter studies such as the EU-funded KidsAP project. His work on hybrid closed-loop systems and glucose monitoring has been published in leading journals, including The New England Journal of Medicine, The Lancet, and Diabetes Care, and has been recognized with international awards such as the ISPAD Young Investigator Award (2018) and national awards including the Langerhans Prize of the Austrian Diabetes Association (2019). Since October 2025, he also holds a postdoctoral position at the Department of Human Movement Sciences, Sport and Health at the University of Graz in the team of Prof. Othmar Moser.
Speaker: Dr. Julia Ware
is a paediatrician and clinical researcher specialising in paediatric diabetes technology at the Charité Berlin and as a Visiting Researcher at the University of Cambridge. She has led key multinational clinical trials on hybrid closed-loop insulin delivery systems in very young children with type 1 diabetes, demonstrating significant improvements in glycemic control and safety. Her doctoral work on the long-term benefits of artificial pancreas systems across paediatric age groups was recognized with the Milo Keynes Prize (2024) from the University of Cambridge.
Learn more about the event here.
More about the event here.
We are looking forward to meeting you in Montreal!
* iPhone and Apple are trademarks ofApple Inc., registered in the US and other countries and regions.